Clinical Trial Update: A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

View source ↗

Summary

A Canadian clinical trial evaluating Teduglutide (Revestive) for Short Bowel Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide (Revestive) (teduglutide)

Snippet

Sponsor: Takeda | Conditions: Short Bowel Syndrome (SBS) | Status: COMPLETED